PENG Jianqiao
Department of Clinical Laboratory, Key Laboratory of Metabonomics of Critical Patients, Hunan Provincial Peoples Hospital & the First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, China;College of Medicine, Hunan Normal University, Changsha, Hunan 410013, ChinaWANG Hongbo
College of Medicine, Hunan Normal University, Changsha, Hunan 410013, ChinaLIANG Xianzhi
College of Medicine, Hunan Normal University, Changsha, Hunan 410013, ChinaLI Cunyan
Department of Clinical Laboratory, Key Laboratory of Metabonomics of Critical Patients, Hunan Provincial Peoples Hospital & the First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, ChinaYE Xiangli
College of Medicine, Hunan Normal University, Changsha, Hunan 410013, China1.Department of Clinical Laboratory, Key Laboratory of Metabonomics of Critical Patients, Hunan Provincial People's Hospital & the First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, China;2.College of Medicine, Hunan Normal University, Changsha, Hunan 410013, China)
R446.1
PENG Jianqiao, WANG Hongbo, LIANG Xianzhi, LI Cunyan, YE Xiangli. Application of combined detection of soluble suppression of tumorigenicity 2 and interleukin-33 in early diagnosis of cardiovascular impairment in children with Kawasaki's disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(10):1016-1020.
Copy